Curtis Banks Group (CBP LN) In line FY update, growth in SIPP numbers during H2 | Dunelm (DNLM LN) Recovery + online gathering momentum, albeit adverse margin mix | Gym Group (GYM LN) Positive YE update but no beat | Instem (INS LN) Pre-close update in line with expectations, major SEND contract win | Midatech Pharma (MTPH LN) IND approval for paediatric brainstem cancer programme MTX110 | NCC Group (NCC LN) Operating improvements starting to come through |

16 Jan 2018
Morning Song

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Song
Dunelm Group plc (DNLM:LON), 1,147 | Gym Group Plc (GYM:LON), 155 | NCC Group plc (NCC:LON), 143 | Biodexa Pharmaceuticals plc Sponsored ADR (BDRX:NAS), 0
- Published:
16 Jan 2018 -
Author:
Singer CM Team -
Pages:
16 -
Curtis Banks Group (CBP LN) In line FY update, growth in SIPP numbers during H2 | Dunelm (DNLM LN) Recovery + online gathering momentum, albeit adverse margin mix | Gym Group (GYM LN) Positive YE update but no beat | Instem (INS LN) Pre-close update in line with expectations, major SEND contract win | Midatech Pharma (MTPH LN) IND approval for paediatric brainstem cancer programme MTX110 | NCC Group (NCC LN) Operating improvements starting to come through |